Madagascar vs Micronesia (Federated States of): Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology

Madagascar
0.6%
in 2024
Micronesia (Federated States of)
0.6%
in 2024
Madagascar rank
60th
Micronesia (Federated States of) rank
60th

Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time

  • Madagascar
  • Micronesia (Federated States of)
00.20.40.60.81201520192024

How they compare

Madagascar currently reports 0.6% against 0.6% in Micronesia (Federated States of), a difference of 0.0%.

Across all 10 years both countries report, Micronesia (Federated States of) has been ahead every year.

Madagascar ranks 60th and Micronesia (Federated States of) ranks 60th of 246 countries.

Micronesia (Federated States of) has averaged higher in every one of the 2 decades both report.

Head to head by decade

Decade Madagascar Micronesia (Federated States of) Difference Ahead
2010s 0.6% 0.9% 0.3% Micronesia (Federated States of)
2020s 0.5% 0.6% 0.1% Micronesia (Federated States of)

Averages of every year both report within each decade.

Frequently asked questions

Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Madagascar or Micronesia (Federated States of)?
Madagascar, at 0.6% against 0.6% in Micronesia (Federated States of) as of 2024.
What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Madagascar and Micronesia (Federated States of)?
0.0%, with Madagascar ahead.
How many years of comparable data are there for Madagascar and Micronesia (Federated States of)?
10 years are reported by both, from 2015 to 2024.
How do Madagascar and Micronesia (Federated States of) rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
Madagascar ranks 60th and Micronesia (Federated States of) ranks 60th of 246 countries.
Where does this data come from?
United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Madagascar vs Micronesia (Federated States of): Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology. Statizoid, drawing on United Nations Statistics Division, SDG Global Database. Retrieved 10 September 2026, from https://development-goals.statizoid.com/compare/prevalence-of-hepatitis-b-surface-antigen-hbsag-2026-methodology-percent/madagascar/micronesia-federated-states-of/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under UN SDG Global Database (open, attribution requested); please keep the attribution.

<a href="https://development-goals.statizoid.com/compare/prevalence-of-hepatitis-b-surface-antigen-hbsag-2026-methodology-percent/madagascar/micronesia-federated-states-of/">Madagascar vs Micronesia (Federated States of): Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology</a> — Statizoid

About this data

Indicator
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%)
Unit
%
Source
United Nations Statistics Division, SDG Global Database
Licence
UN SDG Global Database (open, attribution requested)
Coverage
250 places, 2,500 data points, 2015–2024
Last refreshed